Company / Gross Profit per Share
GeneDx Holdings Corp. Gross Profit per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$10.64
FY2025
5-year range
-$133887.10 / $784.64
FY2021-FY2025
Trend
+42.2%
vs FY2024
Sector context
#43 of 99
Health Care
What the data says
At $10.64, GeneDx Holdings Corp.'s gross profit per share ranks #43 of 99 in the Health Care sector. Gross Profit per Share returned to growth in FY2025 after 2 years of decline, reaching $10.64.
Based on SEC 10-K filings.
10.64 in FY2025 with a 5-year CAGR of -57.7%.
Improved from $7.65 to $10.64 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- -76.2%
- 5-Year CAGR
- -57.7%
- 10-Year CAGR
- -
Sector benchmark
#43 of 99 in Health CareTop 43% of 99This company $10.64 Sector average $13.98
▼
-23.9% below sector average
Key checks
Key Insights
- In FY2025, gross profit per share increased 42.2% year-over-year.
- Ranks #43 out of 99 companies in the Health Care sector.
- Peak gross profit per share was recorded in FY2019.
- Lowest gross profit per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.64 | +42.2% |
| FY2024 | $7.48 | -2.1% |
| FY2023 | $7.65 | -99.0% |
| FY2022 | $784.64 | +100.6% |
| FY2021 | -$133887.10 | -17163.5% |
| FY2020 | $784.64 | -99.9% |
| FY2019 | $667620.97 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026